AbbVie (ABBV) Intangibles (2012 - 2026)

AbbVie (ABBV) has reported Intangibles for 15 consecutive years, with $49.1 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Intangibles fell 13.84% year-over-year to $49.1 billion in Q2 2026; TTM through Jun 2026 was $49.1 billion, a 13.84% decrease from a year earlier, with the FY2025 full-year figure at $52.6 billion, down 12.36% from the prior year.
• Intangibles was $49.1 billion for Q2 2026 at AbbVie, down from $50.9 billion in the prior quarter.
• Over five years, Intangibles peaked at $74.0 billion in Q1 2022 and troughed at $49.1 billion in Q2 2026.
• A 5-year average of $60.9 billion and a median of $60.2 billion in 2024 frame the typical range for Intangibles.
• Across the five-year window, Intangibles climbed 13.72% in 2024 and fell 18.5% in 2025, its largest moves.
• Over 5 years, Intangibles stood at $67.4 billion in 2022, then slipped by 17.54% to $55.6 billion in 2023, then climbed by 8.02% to $60.1 billion in 2024, then decreased by 12.36% to $52.6 billion in 2025, then decreased by 6.65% to $49.1 billion in 2026.
• The last three Intangibles figures came in at $49.1 billion (Q2 2026), $50.9 billion (Q1 2026), and $52.6 billion (Q4 2025), per Business Quant data.